ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs

Immune‐mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is associated with considerable morbidity and mortality. Treatment with various immunosuppressive and antithrombotic drugs has been described anecdotally and in previous studies, but little consensus exists among veterinarian... Ausführliche Beschreibung

1. Person: James W. Swann verfasserin
Weitere Personen: Oliver A. Garden verfasserin; Claire L. Fellman verfasserin; Barbara Glanemann verfasserin; Robert Goggs verfasserin; Dana N. LeVine verfasserin; Andrew J. Mackin verfasserin; Nathaniel T. Whitley verfasserin
Quelle: In Journal of Veterinary Internal Medicine (01.05.2019)
Weitere Artikel
Format: Online-Artikel
Sprache: English
Veröffentlicht: 2019
Beschreibung: Online-Ressource
Online Zugang: Online
Online
Online
Online
Online
Volltext
Tags: Hinzufügen
Keine Tags. Fügen Sie den ersten Tag hinzu!
  Creative Commons License Source: Directory of Open Access Journals (DOAJ).
LEADER 02963nma a2200373 c 4500
001 DOAJ041690958
003 DE-601
005 20190524072435.0
007 cr uuu---uuuuu
008 190524s2019 000 0 eng d
024 7 |a 10.1111/jvim.15463  |2 doi 
035 |a (DE-599)DOAJ59596ba02bfa4a8fb4d3c64459b8fb2c 
040 |b ger  |c GBVCP 
041 0 |a eng 
100 0 |a James W. Swann  |e verfasserin  |4 aut 
245 1 0 |a ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs  |h Elektronische Ressource 
300 |a Online-Ressource 
520 |a Immune‐mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is associated with considerable morbidity and mortality. Treatment with various immunosuppressive and antithrombotic drugs has been described anecdotally and in previous studies, but little consensus exists among veterinarians as to the optimal regimen to employ and maintain after diagnosis of the disease. To address this inconsistency and provide evidence‐based guidelines for treatment of IMHA in dogs, we identified and extracted data from studies published in the veterinary literature. We developed a novel tool for evaluation of evidence quality, using it to assess study design, diagnostic criteria, explanation of treatment regimens, and validity of statistical methods. In combination with our clinical experience and comparable guidelines for humans afflicted with autoimmune hemolytic anemia, we used the conclusions of this process to make a set of clinical recommendations regarding treatment of IMHA in dogs, which we refined subsequently by conducting several iterations of Delphi review. Additionally, we considered emerging treatments for IMHA in dogs and highlighted areas deserving of future research. Comments were solicited from several professional bodies to maximize clinical applicability before the recommendations were submitted for publication. The resulting document is intended to provide clinical guidelines for management of IMHA in dogs. These guidelines should be implemented pragmatically, with consideration of animal, owner, and veterinary factors that may vary among cases. 
700 0 |a Oliver A. Garden  |e verfasserin  |4 aut 
700 0 |a Claire L. Fellman  |e verfasserin  |4 aut 
700 0 |a Barbara Glanemann  |e verfasserin  |4 aut 
700 0 |a Robert Goggs  |e verfasserin  |4 aut 
700 0 |a Dana N. LeVine  |e verfasserin  |4 aut 
700 0 |a Andrew J. Mackin  |e verfasserin  |4 aut 
700 0 |a Nathaniel T. Whitley  |e verfasserin  |4 aut 
773 0 8 |i In  |t Journal of Veterinary Internal Medicine  |g  (01.05.2019)  |w (DE-601)DOAJ000088501  |x 0891-6640 
856 4 0 |u http://dx.doi.org/10.1111/jvim.15463 
856 4 0 |y DOAJ  |u https://doaj.org/article/59596ba02bfa4a8fb4d3c64459b8fb2c 
856 4 0 |u https://doi.org/10.1111/jvim.15463 
856 4 0 |u https://doaj.org/toc/0891-6640 
856 4 0 |u https://doaj.org/toc/1939-1676 
912 |a GBV_DOAJ 
951 |a AR 
952 |j 2019  |b 01  |c 05 

Ähnliche Einträge

Keine ähnlichen Titel gefunden

Privacy Notice Ask a Librarian New Acquisitions